DE60231825D1 - Behandlung von infektionen verursacht von mikroorganismen - Google Patents

Behandlung von infektionen verursacht von mikroorganismen

Info

Publication number
DE60231825D1
DE60231825D1 DE60231825T DE60231825T DE60231825D1 DE 60231825 D1 DE60231825 D1 DE 60231825D1 DE 60231825 T DE60231825 T DE 60231825T DE 60231825 T DE60231825 T DE 60231825T DE 60231825 D1 DE60231825 D1 DE 60231825D1
Authority
DE
Germany
Prior art keywords
microorganisms
treatment
infections caused
antibody
daptomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231825T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neutec Pharma Ltd
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Application granted granted Critical
Publication of DE60231825D1 publication Critical patent/DE60231825D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60231825T 2001-11-22 2002-11-13 Behandlung von infektionen verursacht von mikroorganismen Expired - Lifetime DE60231825D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127983.5A GB0127983D0 (en) 2001-11-22 2001-11-22 Treatment of micro-organism infection
PCT/GB2002/005135 WO2003046007A2 (en) 2001-11-22 2002-11-13 Treatment of micro-organism infection

Publications (1)

Publication Number Publication Date
DE60231825D1 true DE60231825D1 (de) 2009-05-14

Family

ID=9926237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231825T Expired - Lifetime DE60231825D1 (de) 2001-11-22 2002-11-13 Behandlung von infektionen verursacht von mikroorganismen

Country Status (18)

Country Link
US (3) US20050118162A1 (de)
EP (2) EP1964851A1 (de)
JP (1) JP2005511645A (de)
CN (2) CN101254304A (de)
AT (1) ATE427320T1 (de)
AU (2) AU2002339159B2 (de)
BR (1) BR0214363A (de)
CA (1) CA2465072A1 (de)
DE (1) DE60231825D1 (de)
DK (1) DK1446425T3 (de)
ES (1) ES2322756T3 (de)
GB (1) GB0127983D0 (de)
NO (2) NO20042604L (de)
NZ (1) NZ533623A (de)
PL (1) PL369536A1 (de)
PT (1) PT1446425E (de)
RU (1) RU2303460C2 (de)
WO (1) WO2003046007A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5248032B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
JP5248033B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
WO2008132174A1 (en) * 2007-04-27 2008-11-06 Novartis Ag An immunoglobulin composition
ES2537437T3 (es) * 2009-05-18 2015-06-08 Julius-Maximilians-Universität Würzburg Anticuerpos o fragmentos de éstos dirigidos contra un epítopo del Staphylococcus aureus de IsaA o IsaB
SG177653A1 (en) * 2009-07-15 2012-02-28 Aimm Therapeutics Bv Gram-positive bacteria specific binding compounds
US9005579B2 (en) 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
AU2011317021B2 (en) * 2010-10-20 2015-07-09 Medimmune, Llc Methods for processing inclusion bodies
CN110302004B (zh) 2013-05-03 2023-04-28 科尼尔赛德生物医学公司 用于眼部注射的设备和方法
RU2572341C2 (ru) * 2013-09-20 2016-01-10 Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
NZ291659A (en) * 1994-09-06 2001-04-27 Galagen Inc Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
GB9806762D0 (en) * 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection

Also Published As

Publication number Publication date
ES2322756T3 (es) 2009-06-26
JP2005511645A (ja) 2005-04-28
US20080171054A1 (en) 2008-07-17
RU2004118716A (ru) 2005-03-27
CA2465072A1 (en) 2003-06-05
EP1446425B1 (de) 2009-04-01
EP1446425A2 (de) 2004-08-18
PL369536A1 (en) 2005-05-02
NZ533623A (en) 2005-12-23
CN100371348C (zh) 2008-02-27
ATE427320T1 (de) 2009-04-15
GB0127983D0 (en) 2002-01-16
EP1964851A1 (de) 2008-09-03
US20050118162A1 (en) 2005-06-02
WO2003046007A3 (en) 2004-03-11
NO20042604L (no) 2004-06-21
AU2002339159B2 (en) 2008-06-05
NO20081575L (no) 2004-06-21
US20070202116A1 (en) 2007-08-30
AU2008212001A1 (en) 2008-09-25
CN101254304A (zh) 2008-09-03
RU2303460C2 (ru) 2007-07-27
CN1589280A (zh) 2005-03-02
WO2003046007A2 (en) 2003-06-05
AU2002339159A1 (en) 2003-06-10
BR0214363A (pt) 2004-10-26
PT1446425E (pt) 2009-07-01
DK1446425T3 (da) 2009-07-20

Similar Documents

Publication Publication Date Title
NO20081575L (no) Behandling av mikroorganismeinfeksjoner
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
HUP0301003A2 (hu) Kazeinből származó peptidek és terápiás alkalmazásuk
DE602004025576D1 (de) Varianten der faktor-vii- oder -viia-gla-domäne
IL132933A0 (en) Composition for the treatment of diarrheal disease
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
ATE403726T1 (de) Cytokin-proteinfamilie
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
ATE201693T1 (de) Hämoregulierende peptide
GB0203419D0 (en) Peptide
RS49520B (sr) Antimikrobno aktivne smeše
EP1557466A4 (de) Tumorantigenprotein und dessen verwendung
NZ508812A (en) Peptides for the prevention or treatment of HIV
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
ATE212839T1 (de) Hämoregulatorische verbindungen
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
WO2003048187A3 (en) Peptides and use thereof in therapeutic agents against hiv infection
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
DE602004003508D1 (de) Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung
CO4820441A1 (es) Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal
MX9800686A (es) Nueva proteina hmw humana mp52s.
WO2003055904A3 (en) Peptidyl-trna hydrolase from pseudomonas aeruginosa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition